(3-Methoxy-5-methylphenyl)methanol, 95.0%, 100mg

(5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methanol, 95.0%, 5g

ethyl 3-(difluoromethyl)-1H-pyrazole-5-carboxylate, 95.0%, 2g

Sodium 1-dodecanesulfonate 99% 50 g

4-Benzoyloxy-2-azetidinone>98.0%(HPLC)(N)5g

(1R,5S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-1-carboxylic acid, 97%, 500mg

TERT-BUTYL 1-OXO-6-AZASPIRO[3.4]OCTANE-6-CARBOXYLATE, 95.0%, 1g

(2-Bromo-5-(trifluoromethyl)phenyl)boronic acid, 95.0%, 5g

GC capillary column ROTI®Cap-5 MS, 30 m, 0.25 mm, 1.00 µm, 1 Piece(s)

ethyl 5-(2-methylphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g

Magnesium fluorosilicate hexahydrate, min. 98%, pure, 500 g, plastic packaging.

(E)-3-(3,5-DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-1-YL)PHENYL)ACRYLIC ACID, 95%, 10mg

TERT-BUTYL 4-(4-CHLOROPHENYL)-4-OXOBUTYLCARBAMATE, 95.0%, 500mg